Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00353275 · ClinicalTrials.gov registry record · NA
Hyperglycemia in Surgical Infections
A NA study, sponsored by The University of Texas Health Science Center, Houston.
- Terminated
- Registry status
- NA
- Development phase
- 5
- Enrollment target
NCT00353275: Clinical Trial NA study, sponsored by The University of Texas Health Science Center, Houston.
NCT00353275 is a NA study that was terminated before completion, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 5 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00353275, a NA study, was terminated before completion, sponsored by The University of Texas Health Science Center, Houston.
- TERMINATED
- Registry status
- NA
- Development phase
- 5 participants
- Enrollment target
Study Summary
The primary purpose of this study is to evaluate two glycemic control regimens on clinical outcome in patients with necrotizing soft tissue infections. Secondary aim is to evaluate the inflammatory and immune responses to the glycemic control regimens.
Interventions
- DRUG Strict Glycemic control
- DRUG Conventional Glycemic Control
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2009-08 |
| Est. Completion | 2011-07 |
| Phase | NA |
Why NCT00353275 stopped before completion
NCT00353275 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 5 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 2 interventions - of which Strict Glycemic control is the first listed.
NCT00353275 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00353275 about?
NCT00353275 is a clinical study titled "Hyperglycemia in Surgical Infections". The primary purpose of this study is to evaluate two glycemic control regimens on clinical outcome in patients with necrotizing soft tissue infections. Secondary aim is to evaluate the inflammatory and immune responses to the glycemic control regimens.
What is the current status of trial NCT00353275?
This trial is currently terminated. It is a NA study. The enrollment target is 5 participants. The study started on 2009-08. Estimated completion is 2011-07.
What interventions are being tested in trial NCT00353275?
The interventions under investigation include: Strict Glycemic control (DRUG), Conventional Glycemic Control (DRUG).
Who is sponsoring clinical trial NCT00353275?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00353275's enrollment target sits among peer trials
5 1988th of 2000 higher than 5 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia